NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 88 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 110.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | +33.3% | 28,810 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $3,000 | -57.1% | 28,810 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $7,000 | 0.0% | 28,810 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,000 | -30.0% | 28,810 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $10,000 | -16.7% | 28,810 | 0.0% | 0.01% | -25.0% |
| Q4 2017 | $12,000 | 0.0% | 28,810 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $12,000 | -20.0% | 28,810 | 0.0% | 0.01% | -20.0% |
| Q2 2017 | $15,000 | -11.8% | 28,810 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $17,000 | -5.6% | 28,810 | 0.0% | 0.01% | -7.7% |
| Q4 2016 | $18,000 | -30.8% | 28,810 | 0.0% | 0.01% | -27.8% |
| Q3 2016 | $26,000 | +73.3% | 28,810 | 0.0% | 0.02% | +80.0% |
| Q2 2016 | $15,000 | -44.4% | 28,810 | 0.0% | 0.01% | -47.4% |
| Q1 2016 | $27,000 | -28.9% | 28,810 | 0.0% | 0.02% | -29.6% |
| Q4 2015 | $38,000 | -42.4% | 28,810 | 0.0% | 0.03% | -43.8% |
| Q3 2015 | $66,000 | +43.5% | 28,810 | 0.0% | 0.05% | +54.8% |
| Q2 2015 | $46,000 | 0.0% | 28,810 | 0.0% | 0.03% | 0.0% |
| Q1 2015 | $46,000 | -14.8% | 28,810 | 0.0% | 0.03% | -13.9% |
| Q4 2014 | $54,000 | +42.1% | 28,810 | 0.0% | 0.04% | +12.5% |
| Q3 2014 | $38,000 | -11.6% | 28,810 | 0.0% | 0.03% | +3.2% |
| Q2 2014 | $43,000 | -18.9% | 28,810 | 0.0% | 0.03% | -26.2% |
| Q1 2014 | $53,000 | -11.7% | 28,810 | 0.0% | 0.04% | +2.4% |
| Q4 2013 | $60,000 | -21.1% | 28,810 | 0.0% | 0.04% | -33.9% |
| Q3 2013 | $76,000 | -1.3% | 28,810 | 0.0% | 0.06% | -27.1% |
| Q2 2013 | $77,000 | – | 28,810 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 15,575,946 | $14,711,000 | 89.51% |
| Financial Advisory Group | 10,000 | $356,000 | 0.17% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 6,704,067 | $6,332,000 | 0.05% |
| LifePlan Financial Group, Inc | 28,810 | $27,000 | 0.02% |
| Greenwich Wealth Management LLC | 65,066 | $61,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 649,880 | $614,000 | 0.01% |
| LYNCH & ASSOCIATES/IN | 18,000 | $17,000 | 0.01% |
| SII INVESTMENTS INC/WI | 90,315 | $86,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 42,535 | $40,000 | 0.00% |
| SVB WEALTH LLC | 46,262 | $44,000 | 0.00% |